Edition:
United States

Johnson & Johnson (JNJ)

JNJ on New York Consolidated

124.52USD
28 Jul 2016
Change (% chg)

$-0.25 (-0.20%)
Prev Close
$124.77
Open
$124.98
Day's High
$125.00
Day's Low
$124.41
Volume
1,693,786
Avg. Vol
7,137,130
52-wk High
$126.07
52-wk Low
$81.79

Select another date:

Tue, Jul 26 2016

BRIEF-Bristol-Myers Squibb collaborates with Johnson and Johnson for lung cancer research

* Bristol-Myers squibb announces new research collaboration with janssen in immuno-oncology focused on lung cancer

New MDL sought for cases over J&J talc powder and ovarian cancer

A federal judicial panel has been asked to consolidate nearly a dozen lawsuits filed in U.S. federal courts alleging Johnson & Johnson failed to warn women that using its talc-based powders for feminine hygiene could increase their risk of ovarian cancer.

Johnson & Johnson raises 2016 forecast, shares touch record high

Johnson & Johnson on Tuesday raised its full-year 2016 sales and earnings forecasts and reported quarterly results that beat estimates, helped by strength in its prescription drugs business.

UPDATE 4-Johnson & Johnson raises 2016 forecast, shares touch record high

July 19 Johnson & Johnson on Tuesday raised its full-year 2016 sales and earnings forecasts and reported quarterly results that beat estimates, helped by strength in its prescription drugs business.

BRIEF-Johnson & Johnson posts Q2 earnings of $1.43/share

* Q2 earnings per share view $1.68 -- Thomson Reuters I/B/E/S

J&J quarterly sales rise 3.9 pct

July 19 Diversified healthcare company Johnson & Johnson reported a 3.9 percent increase in second-quarter sales, helped by strength in its pharmaceuticals business.

BRIEF-Johnson & Johnson announces completion of Vogue International deal

* Johnson & Johnson announces completion of acquisition of Vogue International Llc Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

BRIEF-Johnson & Johnson sets quarterly cash dividend of $0.80 per share

* Sets quarterly cash dividend of $0.80 per share Source text for Eikon: Further company coverage:

BRIEF-Johnson & Johnson to buy 20 pct stake in CI:Z Holdings Co - Nikkei

* Johnson & Johnson to buy 20 pct of Japanese cosmetics maker - Nikkei

U.S. judge cuts $500 mln verdict over J&J hip implants

NEW YORK A U.S. judge has slashed a $500 million verdict against Johnson & Johnson and its DePuy unit over allegedly defective metal-on-metal Pinnacle hip implants to approximately $151 million.

Select another date: